U.S. GoldMining Inc. (USGO)
NASDAQ: USGO · Real-Time Price · USD
8.20
+0.26 (3.27%)
At close: Jun 26, 2026, 4:00 PM EDT
8.09
-0.11 (-1.34%)
After-hours: Jun 26, 2026, 6:26 PM EDT
Company Description
U.S. GoldMining Inc., an exploration stage company, engages in the exploration and development of mineral properties in the United States.
Its primary asset is the 100%-owned Whistler exploration property, a gold-copper exploration project comprising 377 mining claims covering an area of 217.5 square kilometers located in Yentna Mining District, Alaska.
The company was incorporated in 2015 and is based in Vancouver, Canada. U.S. GoldMining Inc. operates as a subsidiary of GoldMining Inc.
U.S. GoldMining Inc.
| Country | Canada |
| Founded | 2015 |
| IPO Date | Apr 20, 2023 |
| Industry | Other Industrial Metals & Mining |
| Sector | Materials |
| Employees | 10 |
| CEO | Timothy Smith |
Contact Details
Address: 1188 West Georgia Street, Suite 1830 Vancouver, BC V6E 4A2 Canada | |
| Phone | 604-388-9788 |
| Website | usgoldmining.us |
Stock Details
| Ticker Symbol | USGO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001947244 |
| CUSIP Number | 90291W108 |
| ISIN Number | US90291W1080 |
| Employer ID | 37-1792147 |
| SIC Code | 1040 |
Key Executives
| Name | Position |
|---|---|
| Timothy Smith B.Sc., M.Sc., P.Geo | Chief Executive Officer and President |
| Tyler Wong C.A. | Chief Financial Officer, Secretary and Treasurer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 26, 2026 | 424B5 | Filing |
| Jun 11, 2026 | 8-K | Current Report |
| Jun 9, 2026 | 8-K | Current Report |
| May 28, 2026 | SCHEDULE 13G/A | Filing |
| May 22, 2026 | 25-NSE | Filing |
| May 13, 2026 | 10-Q | Quarterly Report |
| May 6, 2026 | 8-K | Current Report |
| Apr 30, 2026 | ARS | Filing |
| Apr 30, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 30, 2026 | DEF 14A | Other definitive proxy statements |